Bio-Rad Laboratories Inc (BIO)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -850,135 | -187,209 | -531,629 | -251,399 | -4,704,258 | -7,829,588 | -2,598,480 | -218,820 | 5,449,000 | 8,564,100 | 5,224,750 | 5,311,210 | 4,910,107 | 4,528,491 | 2,508,851 | 2,032,522 | 2,261,105 | 520,441 | 1,205,746 | 776,198 |
| Revenue (ttm) | US$ in thousands | 2,637,846 | 2,686,946 | 2,731,337 | 2,741,910 | 2,774,598 | 2,777,098 | 2,856,467 | 2,894,713 | 2,922,702 | 2,979,702 | 2,876,119 | 2,701,076 | 2,540,271 | 2,374,971 | 2,288,622 | 2,311,881 | 2,292,289 | 2,284,689 | 2,267,881 | 2,271,474 |
| Pretax margin | -32.23% | -6.97% | -19.46% | -9.17% | -169.55% | -281.93% | -90.97% | -7.56% | 186.44% | 287.41% | 181.66% | 196.63% | 193.29% | 190.68% | 109.62% | 87.92% | 98.64% | 22.78% | 53.17% | 34.17% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-850,135K ÷ $2,637,846K
= -32.23%
The pretax margin for Bio-Rad Laboratories Inc. has shown significant fluctuations over the past eight quarters. In Q4 2023, the company reported a pretax margin of -31.82%, indicating that for every dollar of revenue generated, the company incurred a loss before taxes. This represents a substantial decrease compared to the prior quarter's pretax margin of -6.61% in Q3 2023.
Looking further back, the pretax margin in Q4 2022 was notably lower at -167.87%, reflecting a steep decline in profitability. However, the company managed to improve its performance in the following quarters, showing a gradual recovery with fluctuations in the range of negative margins.
Overall, the pretax margin trend suggests that Bio-Rad Laboratories Inc. has experienced challenges in managing its operating expenses and generating profits. The recent negative margins indicate that the company's cost structure may be a key area for improvement in order to enhance profitability and operational efficiency.
Peer comparison
Dec 31, 2023